| State: | Pennsylvania |
|---|---|
| Address: | 1055 Westlakes Dr, Berwyn, PA 19312 |
| Zip code: | 19312 |
| Phone: | (312) 961-2502 |
Complexa is located in Chester County of Pennsylvania state. On the street of Westlakes Drive and street number is 1055. To communicate or ask something with the place, the Phone number is (312) 961-2502.
The coordinates that you can use in navigation applications to get to find Complexa quickly are 40.063027 ,-75.467335
There are no reviews yet!
You can review this Business and help others by leaving a comment. If you want to share your thoughts about Complexa, use the form below and your opinion, advice or comment will appear in this space.
Complexa Inc. today announced the appointment of Elisabeth Leiderman, MD, MBA, as Chief Business Officer. ... Mike Beyer Sam Brown Inc. 312-961-2502 Contacts.
https://www.businesswire.com/news/home/20200207005023/en/Complexa-Names-Elisabeth-Leiderman-MD-MBA-ChiefComplexa Inc. today announced the appointment of Theodore (Theo) Danoff, MD, PhD, as Chief Medical Officer. ... Media Contact: Mike Beyer Sam Brown Inc. 312-961-2502 mikebeyer@sambrown.com. Contacts
https://www.businesswire.com/news/home/20190819005074/en/Complexa-Names-Theodore-Danoff-MD-PhD-ChiefComplexa Inc., a clinical stage biopharmaceutical company, today announced the appointment of Francisco D. Salva as the company's new Chief Executive ... 312-961-2502 mikebeyer@sambrown.com ...
https://www.businesswire.com/news/home/20180514005595/en/Complexa-Appoints-Francisco-D.-Salva-Chief-Executive-Officer-and-PresidentThe phone number for Complexa is (312) 961-2502. Where is Complexa located? Complexa is located at 1055 Westlakes Dr, Berwyn, PA 19312. Similar businesses near me in Berwyn, PA. Timothy Trotter 1055 Westlakes Dr STE 3152, Berwyn, PA 193122410;
https://us.businessyab.com/explore/complexa-312-961-2502.htmlBERWYN, Pa.--(BUSINESS WIRE)--Complexa Inc. today announced the completion of patient enrollment in the FIRSTx study, a Phase 2 clinical trial evaluating the safety and efficacy of the company's ...
https://www.businesswire.com/news/home/20200603005210/en/Complexa-Completes-Patient-Enrollment-in-Phase-2-FIRSTx-Trial-Evaluating-CXA-10-in-Focal-Segmental-Glomerulosclerosis-a-Rare-and-Severe-Form-of-Kidney-DiseaseFirst Patient Dosed in the Complexa Phase 2 Trial of Lead Candidate CXA-10 to Treat a Rare and Severe Form of Kidney Disease, Focal Segmental Glomerulosclerosis June 01, 2018 08:30 AM Eastern ...
https://www.businesswire.com/news/home/20180601005109/en/First-Patient-Dosed-in-the-Complexa-Phase-2-Trial-of-Lead-Candidate-CXA-10-to-Treat-a-Rare-and-Severe-Form-of-Kidney-Disease-Focal-Segmental-GlomerulosclerosisCorporate and Investor Relations: A. Brian Davis XyloCor Therapeutics brian.davis@xylocor.com 610-541-2056 Media Contact: Mike Beyer Sam Brown Inc. mikebeyer@sambrown.com 312-961-2502 Site Navigation
https://www.businesswire.com/news/home/20220118005096/en/XyloCor-Therapeutics-Expands-Leadership-Team-with-Accomplished-Pharmaceutical-Executives-to-Accelerate-Clinical-Development-Programs-and-Drive-Corporate-GrowthNexImmune is also developing new AIM nanoparticle constructs and modalities for potential clinical evaluation in oncology and in disease areas outside of oncology, including autoimmune disorders ...
https://www.globenewswire.com/news-release/2021/01/04/2152432/0/en/NexImmune-Strengthens-Scientific-Leadership-by-Appointing-Jerome-Zeldis-as-EVP-R-D-and-Jeffrey-Weber-as-Chief-Scientific-Advisor.htmlNabriva Therapeutics Enters into Exclusive Agreement to Promote and Distribute SIVEXTRO® (tedizolid phosphate) in the U.S. ... 312-961-2502. Please see Prescribing Information for SIVEXTRO ...
https://www.globenewswire.com/news-release/2020/07/15/2062852/0/en/Nabriva-Therapeutics-Enters-into-Exclusive-Agreement-to-Promote-and-Distribute-SIVEXTRO-tedizolid-phosphate-in-the-U-S.html